CLINICAL_TRIALS
trial_result
· 2011-07-26
Clinical Trial Update: Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin [Phase 4]
Summary
Phase 4 trial comparing tolerability of MetroGel 1% versus Finacea 15% on split-face in healthy skin; results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Skin Manifestations | Phase 4 | Status: COMPLETED | Results posted: 2011-07-26